Heng‐Ying Pu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Inflammasome and immune disorders
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 6
- RNA Research and Splicing 2
- Advanced biosensing and bioanalysis techniques 1
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 2
- Cancer, Hypoxia, and Metabolism 1
- Co-authors
- Rui‐Hua Xu (8 shared papers)Zexian Liu (7 shared papers)Qi‐Nian Wu (7 shared papers)Huai‐Qiang Ju (4 shared papers)Peishan Hu (3 shared papers)Miao‐Zhen Qiu (2 shared papers)Jin‐Fei Lin (2 shared papers)Yiyu Wang (1 shared paper)
- Journals
- Signal Transduction and Targeted Therapy (2 papers)Cancer Research (2 papers)Journal of Materials Chemistry B (1 paper)Clinical Cancer Research (1 paper)Cancer Letters (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Heng‐Ying Pu
10 papers receiving 485 citations
Heng‐Ying Pu's Hit Papers
Peers
Comparison fields: 5 of 67
- Cancer Research 201
- Molecular Biology 378
- Immunology 80
- Pulmonary and Respiratory Medicine 110
- Oncology 70
Countries citing papers authored by Heng‐Ying Pu
This map shows the geographic impact of Heng‐Ying Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng‐Ying Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng‐Ying Pu more than expected).
Fields of papers citing papers by Heng‐Ying Pu
This network shows the impact of papers produced by Heng‐Ying Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng‐Ying Pu. The network helps show where Heng‐Ying Pu may publish in the future.
Co-authors
The 25 scholars most cited alongside Heng‐Ying Pu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis Hit paper breakdown → | 2022 | 226 |
| 2 | 2021 | 59 | |
| 3 | 2020 | 46 | |
| 4 | 2015 | 40 | |
| 5 | 2022 | 37 | |
| 6 | 2023 | 30 | |
| 7 | 2017 | 25 | |
| 8 | 2024 | 14 | |
| 9 | 2018 | 8 | |
| 10 | 2022 | 6 |
About Heng‐Ying Pu
Heng‐Ying Pu is a scholar working on Molecular Biology, Cancer Research, Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 10 papers that have together received 491 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (2 papers), RNA Research and Splicing (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Telomeres, Telomerase, and Senescence (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Cholesterol and Lipid Metabolism (1 paper). The work is most often cited by research in Cancer Research (201 citations), Molecular Biology (378 citations), Immunology (80 citations), Pulmonary and Respiratory Medicine (110 citations) and Oncology (70 citations). Heng‐Ying Pu has collaborated with scholars based in China and United States. Frequent co-authors include Rui‐Hua Xu, Zexian Liu, Qi‐Nian Wu, Huai‐Qiang Ju, Peishan Hu, Miao‐Zhen Qiu, Jin‐Fei Lin, Yiyu Wang, Junzhong Lin and Ting Li. Their work appears in journals such as Signal Transduction and Targeted Therapy, Cancer Research, Journal of Materials Chemistry B, Clinical Cancer Research and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.